Sillaze, additionally, the St. Louis laboratories develop Phase 3 commercial processes and transfer this technology to Pfizer Global Supply. Could we be on to something here...
The ASX Today: XJO nervous as Iran War fret (and a lack of any AI stocks) make Australian bourse dull